Combined pulmonary fibrosis and emphysema syndrome: the age of majority
European Respiratory Journal · 2024
DOI: 10.1183/13993003.00353-2024 ↗Kurz gefasst
Editorial in der Zeitschrift European Respiratory Journal, 2024. Verfasst von Vincent Cottin. Beteiligte Einrichtung: Department of Respiratory Medicine, National Reference Centre for Rare Pulmonary Diseases, ERN-LUNG, Louis Pradel Hospital, Hospices Civils de Lyon, …. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Pulmonary Emphysema, Emphysema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Shareable abstract Patients with combined pulmonary fibrosis and emphysema clinical syndrome have an increased risk of complications (pulmonary hypertension, lung cancer and mortality) compared to those with IPF and no emphysema or emphysema less than 10–15%https://bit.ly/4a4viNJ
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Respiratory Medicine, National Reference Centre for Rare Pulmonary Diseases, ERN-LUNG, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France vincent.cottin@chu-lyon.fr.
- UMR 754, INRAE, Claude Bernard University Lyon 1, Lyon, France.
ORCID-Profile: Vincent Cottin
Zitieren
APA
Cottin, V. (2024). Combined pulmonary fibrosis and emphysema syndrome: the age of majority. European Respiratory Journal. https://doi.org/10.1183/13993003.00353-2024
Vancouver
Cottin V. Combined pulmonary fibrosis and emphysema syndrome: the age of majority. European Respiratory Journal. 2024. doi:10.1183/13993003.00353-2024
BibTeX
@article{Cottin2024,
author = {Cottin, Vincent},
title = {Combined pulmonary fibrosis and emphysema syndrome: the age of majority},
journal = {European Respiratory Journal},
year = {2024},
doi = {10.1183/13993003.00353-2024}
}
EUVIMED